BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
247 Results
Year
Month
Day
  • Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that David Meline has joined Moderna as Chief Financial Officer, effective Monday, June 8, 2020.
  • Streamline Health Solutions, Inc. (NASDAQ:STRM), provider of integrated solutions, technology-enabled services and analytics supporting revenue cycle optimization for healthcare enterprises today announced that it will release its first quarter 2020 financial performance for the period that ended April 30, 2020, on Wednesday, June 10, 2020 after the close of the financial markets. The Company will conduct a conference call to review the resu
  • Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that it has regained the worldwide rights to JTX-8064 from Bristol Myers Squibb. JTX-8064 is a highly-selective, potential first-in-class antibody that targets the Leukocyte Immunoglobulin Like Receptor B2 (LILRB2) on macrophages, and was licensed to Celgene in J
  • Reflect Scientific, Inc. (Symbol:RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announced a record first quarter in sales. In 2019 new market opportunities were sought in the biopharmaceutical and natural products extraction markets. The result was an improved blast freezer design with first in class specifications for the biopharmaceutical market and a solvent chiller for na
  • Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for a U.S. patent, which will be issued to the Company, titled “Devices and Methods for On-Line Whole Blood Treatment” regarding the Company’s Selective Target Anti
  • Pendulum Therapeutics , a cutting-edge microbiome company dedicated to making people healthier through microbiome-targeted solutions, announced today the launch of Pendulum Glucose Control, the first and only medical probioti
  • MedHub Ltd., a medical technology company focused on developing and commercializing AI powered medical solutions that aid in the diagnosis of cardiac disease, announced that is has gained AMAR approval for its AutocathFFR system.
  • Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the successful completion of independent examinations for SOC 2 Type 2, SOC 3 and HIPAA. The examinations were conducted by independent service auditor Schellman and Company, LLC. These additions to the Seven Bridges compliance portfolio complement the compa
  • Taiho Oncology, Inc. today announced that preclinical data for futibatinib (TAS-120) will be presented online during the American Association for Cancer Research (AACR) Virtual Annual Meeting II 2020 from June 22-24 . Key presentations include:
  • Silverback Therapeutics (“Silverback”), a biopharmaceutical company advancing a pipeline of therapies that are systemically delivered, but locally active, today announced the appointment of Vickie L. Capps as director and audit committee chair. “Vickie has had a distinguished career in finance and executive leadership, and I was fortunate to have her guidance on the board of Synthorx,” said Laura Shawver, Ph.D., president, c